CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination with GLP-1 RAs. While GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback